首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9983篇
  免费   604篇
  国内免费   136篇
耳鼻咽喉   151篇
儿科学   206篇
妇产科学   106篇
基础医学   1703篇
口腔科学   166篇
临床医学   848篇
内科学   2101篇
皮肤病学   517篇
神经病学   730篇
特种医学   587篇
外科学   1160篇
综合类   63篇
现状与发展   1篇
一般理论   1篇
预防医学   357篇
眼科学   242篇
药学   940篇
中国医学   180篇
肿瘤学   664篇
  2024年   5篇
  2023年   61篇
  2022年   205篇
  2021年   378篇
  2020年   206篇
  2019年   260篇
  2018年   336篇
  2017年   257篇
  2016年   366篇
  2015年   477篇
  2014年   587篇
  2013年   588篇
  2012年   916篇
  2011年   897篇
  2010年   496篇
  2009年   454篇
  2008年   600篇
  2007年   545篇
  2006年   454篇
  2005年   484篇
  2004年   339篇
  2003年   310篇
  2002年   276篇
  2001年   199篇
  2000年   199篇
  1999年   149篇
  1998年   60篇
  1997年   39篇
  1996年   41篇
  1995年   18篇
  1994年   41篇
  1993年   19篇
  1992年   48篇
  1991年   55篇
  1990年   50篇
  1989年   63篇
  1988年   35篇
  1987年   33篇
  1986年   28篇
  1985年   25篇
  1984年   13篇
  1983年   6篇
  1981年   9篇
  1980年   16篇
  1979年   17篇
  1978年   9篇
  1977年   9篇
  1976年   5篇
  1969年   4篇
  1967年   6篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.

Background and aims

It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.

Methods and results

As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.

Conclusions

In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes.  相似文献   
7.
ABSTRACT

Genotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号